UNITED
STATES
|
OMB
APPROVAL
|
||
SECURITIES
AND EXCHANGE COMMISSION
|
OMB Number |
3235-0080
|
|
Washington,
D.C. 20549
|
Expires |
February
28, 2009
|
|
Estimated average burden | |||
hours per response |
1.00
|
Issuer:
Interpharm Holdings, Inc. Exchange:
American Stock Exchange, LLC
|
(Exact
name of Issuer as specified in its charter, and name of Exchange
where
security is listed and/or
registered)
|
75
Adams Avenue, Hauppauge, NY 11788, Tel: 631-952-0214
|
(Address,
including zip code, and telephone number, including area code,
of
Issuers’s principal executive
offices)
|
Common
Stock, par value $.01 per Share
|
(Description
of class securities)
|
5/1/2008
|
By |
/s/
Peter Giallorenzo
|
Chief
Financial Officer
|
||
Date
|
Name
|
Title
|
SEC1654(03-06)
|
Persons
who respond to the collection of information contained in this form
are
not required to respond unless the form displays a currently valid
OMB
control number
|